# Glaxosmithkline Puerto Rico, INC. 401(k) Plan
Source: https://planprovider.pro/companies/glaxosmithkline-puerto-rico-inc-401k-plan

> Glaxosmithkline Puerto Rico, INC.'s 401(k) plan: 16 participants, plan year 2024 financials, providers, and benchmarks from Form 5500.

Form 5500 filing data for plan year 2024.

## Plan Snapshot

- **Plan Sponsor:** Glaxosmithkline Puerto Rico, INC.

- **Sponsor EIN:** 660613421

- **Sponsor Address:** FMC TOWER AT CIRA CENTRE SOUTH, PHILADELPHIA, PA, 19104

- **Plan Type:** 401(k)

- **Total Participants:** 16

- **Total Assets:** $57.1M

## Key Plan Design Features

- **Auto-Enrollment:** Yes

- **Auto-Escalation:** No

- **Allows Roth Contributions:** No

- **Participant Loans:** No

- **Participant-Directed Investments:** Yes

- **ERISA Section 404(c) Fiduciary Safe Harbor:** Yes

## Plan Financials by Year

| Year|Participants|Total Assets|Employer Contrib.|Employee Contrib.|

| 2024|16|$57.1M|$272,757|$232,113|

| 2023|18|$55.5M|$286,231|$239,902|

| 2022|18|$52.2M|$3.0M|$2.6M|

## Service Providers (Schedule C)

Vendors paid $5,000 or more for services to the plan, ranked by total compensation (direct + indirect fees).

| Provider Name|
Role|
Direct Compensation|
Indirect Compensation|
Total Fees|

| DELOITTE & TOUCHE LLP|Auditor|—|—|$0|

### Verified Provider Profiles

Direct links to verified profiles of matched retirement plan providers on PlanProvider.Pro:

- [DELOITTE & TOUCHE LLP](https://planprovider.pro/provider/deloitte-and-touche-llp) — Auditor

## Plan Fees & Expenses

Annual service provider fees and administrative expenses sourced from DOL Form 5500 filings.

- **Total Service Provider Fees:** $0

### Historical Administrative Expenses

Breakdown of administrative expense categories reported on Form 5500 filings.

| Year|
Total Admin Expenses|
Investment Mgmt Fees|
Contract Admin Fees|
IQPA Audit Fees|
Professional Fees|

| 2024|$4,220|—|—|—|—|

| 2023|$12,455|—|—|—|—|

| 2022|$4,585|$4,585|—|—|—|

## Similar Plans

- [Meda Pharmaceuticals INC.](https://planprovider.pro/companies/meda-pharmaceuticals-inc-plan) — 11 participants

- [Akorn Operating Company LLC](https://planprovider.pro/companies/akorn-operating-company-llc-401k-plan) — 0 participants

- [Arbutus Biopharma INC](https://planprovider.pro/companies/arbutus-biopharma-inc-401k-plan) — 39 participants

- [Csl Behring LLC](https://planprovider.pro/companies/csl-behring-llc-plan-110) — 41 participants

- [Therakos, LLC](https://planprovider.pro/companies/therakos-llc-plan) — 79 participants

- [Mylan Pharmaceuticals INC.](https://planprovider.pro/companies/mylan-pharmaceuticals-inc-401k-plan) — 81 participants

[View full interactive plan profile on PlanProvider.Pro](https://planprovider.pro/companies/glaxosmithkline-puerto-rico-inc-401k-plan)

© 2026 PlanProvider.Pro